ClinicalTrials.Veeva

Menu

Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds

M

MolecuLight

Status

Unknown

Conditions

Wound

Treatments

Device: MolecuLight i:X Imaging Device

Study type

Observational

Funder types

NETWORK
Industry

Identifiers

Details and patient eligibility

About

This is a non-randomized evaluation for which 160 adult patients will be imaged at outpatient wound care clinics who present with a wound of unknown infection diagnostic status and are receiving standard treatment. The MolecuLight i:X Imaging Device will be used as an adjunctive tool in the assessment of the wound and may be used to guide the targeted sampling of a wound (using a conventional punch biopsy method).

Enrollment

367 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male and female subjects presenting at an advanced outpatient wound care clinic with wound(s) (e.g. DFU, VLU, PU, SSI)
  • 18 years or older

Exclusion criteria

  • Treatment with an investigational drug within 1 month before study enrolment
  • Subjects with recent (<30 days) biopsy of target wound
  • Subjects with wounds that cannot be completely imaged by study device due to anatomic location
  • Inability to consent
  • Any contra-indication to routine wound care and/or monitoring

Trial contacts and locations

14

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems